Clinical trial
A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3
NCT00002185 is registered in ClinicalTrials.gov with Agouron Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3
- Lead sponsor
- Agouron Pharmaceuticals
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- 20
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.